Oct. 30 2024
Source Page: Amivantamab with lazertinib for untreated EGFR mutation-positive advanced non-small-cell lung cancer ID6256Found: and scoping workshop discussion), and, if so, what are they?
Aug. 23 2024
Source Page: Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancerFound: peritoneal cancer (Review of TA611) 1 of 2 Issue date: August 2024 NATIONAL INSTITUTE FOR HEALTH AND
Oct. 25 2024
Source Page: Omaveloxolone for treating Friedreich's ataxia in people 16 years and over ID6423Found: Omaveloxolone for treating Friedreich's ataxia in people 16 years and over ID6423
Aug. 08 2024
Source Page: Futibatinib for previously treated advanced cholangiocarcinoma with FGFR2 fusion or rearrangementFound: fusion or rearrangement [ID6302] 1 of 2 Issue date: August 2024 NATIONAL INSTITUTE FOR HEALTH AND
Aug. 22 2024
Source Page: Lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID4043]Found: , and, if so, how ?
Oct. 16 2024
Source Page: Funding awarded by the Equality and Human Rights Fund: FOI releaseFound: Funding awarded by the Equality and Human Rights Fund: FOI release
Oct. 31 2024
Source Page: Leniolisib for activated phosphoinositide 3-kinase delta syndrome in people 12 years and over [ID6130]Found: Leniolisib for activated phosphoinositide 3-kinase delta syndrome in people 12 years and over [ID6130
Aug. 08 2024
Source Page: Evinacumab for treating homozygous familial hypercholesterolaemia in people 12 years and overFound: Evinacumab for treating homozygous familial hypercholesterolaemia in people 12 years and over
Aug. 29 2024
Source Page: Compression products for venous leg ulcers: late stage assessmentFound: Page 1 of 2 NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE HealthTech programme Equality
Aug. 28 2024
Source Page: Linzagolix for treating pain caused by endometriosis [ID6357]Found: evaluation according to the principles of the NICE Equality scheme. 1.